Overcoming Development Challenges of Inhaled Liposomal Formulations
Time: 2:30 pm
day: Conference Day 1
Details:
- Discussing the advantages of use liposomal formulations
- Assessing challenges with developing liposomal formulations
- Outlining a case study of ALIS (Amikacin Liposome Inhalation Suspension)
